Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults

Abstract Objective Darunavir (DRV) is a P-glycoprotein (P-gp) inhibitor. Dabigatran etexilate, prodrug of the anticoagulant dabigatran, is a P-gp probe substrate. This study evaluated the effect of single and multiple doses of DRV, coadministered with cobicistat (COBI) or ritonavir (rtv), on the pha...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sandy Van Hemelryck, Erika Van Landuyt, Jay Ariyawansa, Martyn Palmer, Martine J. C. Kothe, Caroline Pollefliet
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	SpringerOpen 2024-10-01
Saila:	AAPS Open
Gaiak:	Darunavir Ritonavir Cobicistat Dabigatran Drug-drug interaction
Sarrera elektronikoa:	https://doi.org/10.1186/s41120-024-00097-w
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!